The present invention is in the field of in-vivo imaging, in particular, systems configured for detecting the position of an in-vivo device based on sensing external light.
Swallowable in-vivo devices are well known for diagnosis of the gastrointestinal (GI) tract. A common design of such devices is a swallowable capsule which includes an outer shell having at least one transparent region (usually a dome of the shell), and an imaging system received or contained within the shell and configured for obtaining in-vivo images of the GI tract while passing through it. These images are stored on a storage device within the capsule itself (to be later retrieved) or, more commonly, are transmitted from the capsule to an external data recorder.
Many of these capsules include communication means through which the external data recorder can not only obtain the images taken by the imaging system, but also receive additional information regarding the capsule, for example, its position along the GI tract.
One example of such a capsule can include an imaging system and an ultra-low power radio frequency transmitter for transmitting signals from the CMOS imaging camera to a receiving system located outside a patient. Embodiments of the imaging system may include at least one CMOS imaging camera, at least one illumination source for illuminating an in vivo site and an optical system for imaging the in vivo site onto the CMOS imaging camera.
Acknowledgement of the above references herein is not to be inferred as meaning that these are in any way relevant to the patentability of the presently disclosed subject matter.
In accordance with one aspect of the present application there is provided a system for detecting the position of an in-vivo device based on external light, said system including an in-vivo device for being introduced into a body and having at least one sensor configured for sensing light, and an ex-vivo module comprising at least one illumination source configured for emitting an indication light towards said body to be sensed by said at least one sensor.
The ex-vivo module can be configured for being fitted externally to a patient's body. In particular, the ex-vivo module can be configured for being fitted to the skin such that the at least one illumination source is directed inwards towards the body.
The ex-vivo module may constitute a part of a device to be manipulated by an operator, such as a handle, a rod etc. Alternatively, the ex-vivo module can be part of a stationary device configured for accommodating the patient, similar to an x-ray or MRI machine.
In accordance with another example, the ex-vivo module may be in the form of a patch configured for being placed against the skin. The patch can be connected to external devices in a wired or wireless manner. The patch can have a contact surface configured for facing the body when fitted thereto, and said illumination source can have at least one light emitting point located on said contact surface.
The in-vivo device may include a communication module configured for receiving alert signals from and/or transmitting alert signals to an ex-vivo device/location. The communication module may be configured for transmitting/receiving said alert signals at least upon detection of said indication light.
The ex-vivo module may be fitted to the body at a predetermined location, whereby transmitting/receiving said alert signals by the in-vivo device indicates a position of the in-vivo device inside the body corresponding to the position of the ex-vivo module.
The in-vivo device may include an imager configured for obtaining in-vivo images. The in-vivo device can be configured for obtaining said in-vivo images in a first operational mode and for switching to obtaining said in-vivo images in a second operational mode when said sensor detects said indication light. The operational modes may differ from one another, inter alia, in the frame rate of capturing images and/or the resolution of the images. Alternatively, the in-vivo device may be configured for commencing imaging upon detection of the indication light by said sensor. In this case, the difference between modes is on/off.
In addition, the in-vivo device may have an on-board (e.g. part of the in-vivo device, or internal to the in-vivo device) illumination source configured for providing light for obtaining images by the imager. Furthermore, the on-board illumination source and the illumination source of the ex-vivo module may be synchronized such that their lighting time does not fully overlap. This may be performed in order for the images obtained by the imager of the in-vivo module (facilitated by the on-board illumination source) to not be affected by the external light provided by the illumination source of the ex-vivo module (e.g. over/under exposure).
Synchronization between the light sources can be performed, for example, by:
The system can further include a progress regulating component configured for slowing down and/or stopping the in-vivo device at a certain location. For example, the progress regulating component can be configured for using magnetic forces to perform said slowing down/stopping. The progress regulating component can also constitute a part of the ex-vivo module.
The progress regulating component may be used if the location of the patch corresponds to a portion of the GI tract in which the movement of the in-vivo module may be expected to be faster. In particular, under one example of the present application, the patch can be placed at a location roughly corresponding to McBurney's point, a point located ⅓ of the way between the navel and the hip bone, and indicative of the location of the appendix (and consequently, the cecum). Thus, positioning the ex-vivo module there, may also give an indication to the position of the cecum. Since in the cecum (after leaving the small bowel), the in-vivo module is expected to progress considerably faster, the progress regulating component may facilitate slowing the in-vivo module specifically there.
In accordance with another aspect of the subject matter of the present application, there is provided a method for detecting the position of an in-vivo device based on external light using, for example, the system of the previous aspect (or another system), the method including, when said in-vivo device is located within the body:
An embodiment may also include receiving/transmitting alert signals to/from said in-vivo device once said indication light is detected.
In accordance with one example of the above, an embodiment may also include obtaining said in-vivo images in a first operational mode before detection of said indication light, and switching to obtaining said in-vivo images in a second operational mode upon such detection.
According to yet another aspect of the present invention, there is provided an ex-vivo module constituting a part of the system (e.g., of the previous aspect of the present application), wherein said ex-vivo module includes an operative surface configured for facing a patient when fitted thereto, and at least one illumination source configured for emitting an indication light at a predetermined wavelength range, wherein said illumination source is facing in the same direction as the contact surface.
In order to better understand the subject matter that is disclosed herein and to exemplify how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn accurately or to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity, or several physical components may be included in one functional block or element. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.
In the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the invention. However, it will be understood by those skilled in the art that the present invention may be practiced without these specific details. In other instances, well-known methods, procedures, and components, modules, units and/or circuits have not been described in detail so as not to obscure the invention. Some features or elements described with respect to one embodiment may be combined with features or elements described with respect to other embodiments. For the sake of clarity, discussion of same or similar features or elements may not be repeated.
Attention is first drawn to
Another example of the ex-vivo module is shown in
The patch 12 is formed with an inner contact surface 14 configured for being placed against a designated area (e.g. the skin of a patient), and an external surface 16. The LED 22 is located proximal to the contact surface 14 so that, when the patch 12 is fitted or attached (e.g. externally) to the designated surface, light rays L emitted from the LED 22 are directed towards the designated surface. Specifically, if the patch 12 is fitted to the skin of a patient (e.g. by adhesion, as common in skin-placed sensors/patches), the light rays L are directed into the patient through his/her skin S (shown in
Turning now to
It is important to note that while the examples given here refer to a gastrointestinal use, embodiments of the present invention are applicable to a combination of an in-vivo device configured for sensing light external to the body.
It is appreciated that, in its most basic configuration, the monitoring system including the ex-vivo module 10 and the in-vivo device 70, can provide an indication to the position of the in-vivo device within the GI tract, or, more precisely, indicate when the in-vivo device 70 has reached a given location within the GI tract. The basic configuration will now be described with respect to
In
In the position shown in
In the position shown in
It is noted that the ex-vivo module 10 can be connected to a data recorder 30, which is configured for receiving data from the ex-vivo module 10 and processing it to determine location/position of the capsule 70.
Since portions of the SB may overlap with the cecum (be located behind it or very close to it), it is possible that the capsule 70, when passing through such a portion of the SB, will sense a certain amount of light L emitted from the LED reaching the SB portion. In this case, the processor PRCS can be configured for registering and analyzing this data, e.g. by duration and/or intensity of the captured light, or by analyzing the imager data (in case the capsule further includes an imager as detailed with regards to another example of a capsule) and, once the capsule actually reaches the cecum, process the data and deduce that the first alert signals received from the capsule 70 were false, and were sent when the capsule 70 was still in the aforementioned SB portion and not in the cecum.
Turning to
As shown in
It is noted from
With particular reference being made to
It is appreciated that steps 130 and 140 of the above described method can be performed repeatedly and/or continuously in order to respectively obtain periodical and/or continuous information on the position of the in-vivo device.
In accordance with another embodiment of the present invention, the capsule 70 may include an imager, which is configured for capturing images throughout its progression along the GI tract, and transmit these images to the communication unit 24. In such case, while the capsule 70 can also include a sensor 74 for detecting the light L from the ex-vivo module 10, it is possible to detect such light using the imager alone, not requiring an additional sensor.
In particular, external light can affect the images captured by the in-vivo device 70, in what is called a ‘halo’ effect—creating a halo of light around the captured image. Thus, the processor can be configured for identifying captured images containing such a ‘halo’ effect in order to indicate if the capsule 70 indeed reached the location corresponding to that of the ex-vivo module 10.
It is known that the progression of the in-vivo device through the cecum is considerably more rapid that its progression along the small intestine. As such, it may be desired to perform for example:
Thus, if the ex-vivo module 10 is properly positioned at the area of the cecum, in accordance with the above example, operations such as the following may occur:
It is noted that during the passage of the capsule 70 through the cecum, the light L can be switched off, at least periodically, in order to prevent damaging of the images captured in the cecum by the halo effect.
It is appreciated that, in case the capsule 70 has an on-board imaging system configured for obtaining images of the GI tract, such a system can also comprise an illumination source as known per se (not shown). Thus, in accordance with a specific example, the DR 30, the LED 22 and illumination source of the imaging system of the capsule 70 can all be synchronized so that when the illumination source is switched on to facilitate obtaining an image of the GI tract, the LED 22 is respectively switched off in order to prevent, for example, a halo effect in the obtained image.
Synchronizing the lighting of the LED 22 and the illumination source can be controlled by the DR 30, and at least the two following configurations are possible:
When the capsule 70 leaves the area of the cecum, for example in a process reverse to the described above, the frame rate can be switched back to FR1, or to any other frame rate specifically designed for capturing images in the colon.
Alternatively, in accordance with another example, the imager of the in-vivo module 70 can be configured for dual-use—a main use as an imager and a secondary use as a light sensor. Specifically, it is appreciated that the imager of the in-vivo module 70 may have no shutter, e.g. each time it is required to acquire a new image, the image sensor needs to be electronically ‘wiped’ clean. This is performed in a given frequency in accordance with the requirements of the in-vivo device.
In accordance with one embodiments, it is suggested, in the intervals between acquisition of images by the imager, to perform an additional ‘wipe’ of the image sensor, and using it merely for detecting the presence of light. In other words, the imager in one embodiment operates at two alternating modes:
Image acquisition mode—the sensor is ‘wiped’ a first time and an image is acquired; and
Light sensing mode—the sensor is ‘wiped’ a second time and only the presence of light over a predetermined threshold is recorder. It is important to note that in this mode, no image is provided by the imager to the data recorder 30. Instead, the data recorder 30 only receives a yes/no alert signal regarding the presence of light above a predetermined threshold.
With additional reference being made to
With reference now being made to
With addition reference being made to
Those skilled in the art to which this invention pertains will readily appreciate that numerous changes, variations, and modifications can be made without departing from the scope of the invention, mutatis mutandis.
Descriptions of embodiments of the invention in the present application are provided by way of example and are not intended to limit the scope of the invention. The described embodiments comprise different features, not all of which are required in all embodiments. Some embodiments utilize only some of the features or possible combinations of the features. Variations of embodiments of the invention that are described, and embodiments comprising different combinations of features noted in the described embodiments, will occur to a person having ordinary skill in the art. The scope of the invention is limited only by the claims.
Unless explicitly stated, the method embodiments described herein are not constrained to a particular order in time or chronological sequence. Additionally, some of the described method elements may be skipped, or they may be repeated, during a sequence of operations of a method.
While certain features of the invention have been illustrated and described herein, many modifications, substitutions, changes, and equivalents may occur to those skilled in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.
Various embodiments have been presented. Each of these embodiments may of course include features from other embodiments presented, and embodiments not specifically described may include various features described herein.
This application is a National Phase Application of PCT International Application No. PCT/IL2018/050305, International Filing Date Mar. 15, 2018, claiming the benefit of U.S. Provisional Patent Application No. 62/472,146, filed Mar. 16, 2017 which are hereby incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IL2018/050305 | 3/15/2018 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/167793 | 9/20/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
6273904 | Chen | Aug 2001 | B1 |
7009634 | Iddan et al. | Mar 2006 | B2 |
7016714 | Colvin, Jr. | Mar 2006 | B2 |
7118529 | Glukhovsky | Oct 2006 | B2 |
8540623 | Blijevsky | Sep 2013 | B2 |
8731637 | Kawano | May 2014 | B2 |
10531788 | Wang | Jan 2020 | B2 |
20040176669 | Colvin, Jr. | Sep 2004 | A1 |
20040199073 | Ma | Oct 2004 | A1 |
20040249245 | Irion | Dec 2004 | A1 |
20050029437 | Hasegawa | Feb 2005 | A1 |
20050043583 | Killmann | Feb 2005 | A1 |
20050043634 | Yokoi | Feb 2005 | A1 |
20050049488 | Homan | Mar 2005 | A1 |
20050228299 | Banet | Oct 2005 | A1 |
20060036164 | Wilson | Feb 2006 | A1 |
20060169293 | Yokoi | Aug 2006 | A1 |
20060173498 | Banville | Aug 2006 | A1 |
20060195014 | Seibel | Aug 2006 | A1 |
20070002038 | Suzuki | Jan 2007 | A1 |
20070066868 | Shikii | Mar 2007 | A1 |
20070118018 | Gilad | May 2007 | A1 |
20080051633 | Blijevsky | Feb 2008 | A1 |
20080119740 | Iddan | May 2008 | A1 |
20080228066 | Waitzman | Sep 2008 | A1 |
20090012369 | Robinson | Jan 2009 | A1 |
20090046821 | Shigemori | Feb 2009 | A1 |
20090124874 | Gono | May 2009 | A1 |
20090182224 | Shmarak | Jul 2009 | A1 |
20100312128 | Karst | Dec 2010 | A1 |
20110166442 | Sarvazyan | Jul 2011 | A1 |
20110319727 | Ishihara | Dec 2011 | A1 |
20120238812 | Blijevsky | Sep 2012 | A1 |
20130027267 | Homan | Jan 2013 | A1 |
20130046150 | Devanaboyina | Feb 2013 | A1 |
20130237774 | Schentag | Sep 2013 | A1 |
20130289558 | Reid, Jr. | Oct 2013 | A1 |
20140031642 | Kimchy et al. | Jan 2014 | A1 |
20150011829 | Wang | Jan 2015 | A1 |
20150297066 | Yanagidate | Oct 2015 | A1 |
20170340243 | Jain | Nov 2017 | A1 |
20190329045 | Cao | Oct 2019 | A1 |
20200022614 | Khait | Jan 2020 | A1 |
Entry |
---|
First Office Action issued in corresponding Chinese applicaiton 201880015545.6 dated Jul. 22, 2021 (Chinese language) (5 pages). |
Second Office Action issued in corresponding Chinese Application No. 201880015545.6 dated Dec. 22, 2021 (Chinese language only) (6 pages). |
Number | Date | Country | |
---|---|---|---|
20200022614 A1 | Jan 2020 | US |
Number | Date | Country | |
---|---|---|---|
62472146 | Mar 2017 | US |